Melola Discovery

← Melola Discovery

Open access Journal SINTA 1

Comparison between Exposure of Ciprofloxacin and Cefotaxime on Developing of Escherichia coli ESBL

Folia Medica Indonesiana · Vol. 56 No. 2 (2020) · pp. 86–86

DOI
10.20473/fmi.v56i2.21203
ISSN
2355-8393, 2599-056X
Published
2020-08-06
Publisher
Airlangga University
Language
en
License
creativecommons.org/licenses/by-nc-sa/4.0/

Abstract

This study aimed to compare ciprofloxacin and cefotaxime exposure to develop ESBL producing Escherichia coli (E. coli). A total of 16 isolates of cefotaxime sensitive E. coli and ciprofloxacin were exposed to ciprofloxacin and cefotaxime for 14 days using the Kirby-Bauer antibiotic disc diffusion method. Colonies that grew on the edge of the inhibiting zone were exposed each day by the same method. Furthermore, we observed the occurrence of resistance to cefotaxime as ESBL screening test. Isolates were resistant, the following day the ESBL was confirmed by the Modified Double Disk Sinergy Test (MDDST) method using Cefotaxime (CTX), Ceftazidime (CAZ), Aztreonam (ATM), and Amoxilin Clavulanate (AMC) antibiotic discs. From 16 isolates of ESBL producing E. coli exposed to ciprofloxacin, it was obtained 4 (25%) to ESBL E. coli. ESBL production occurred after E. coli was exposed to ciprofloxacin on days 5, 6, 7, and 12. While those exposed to cefotaxime none becomes ESBL E. coli. There was no difference between ciprofloxacin and cefotaxime exposure to develop ESBL producing E. coli (p=0.101; Chi-square).

Keywords

Collaboration network of the authors

40 authors · 120 co-authorship links · 48 across different organisations · showing the 40 most connected

Hover or tap a name to highlight its co-authors. Double-click to open the author's page.

  • Universitas Airlangga
  • Muhammadiyah University of Yogyakarta
  • Institut Teknologi Sepuluh Nopember
  • STIKES Hang Tuah Surabaya
  • National Research and Innovation Agency
  • Rumah Sakit Dokter Soetomo
  • University of Malaya
  • Other organisations
  • Affiliation unknown
  • Different organisations
  • Same organisation
  • Affiliation unknown
  • Thicker line = more joint articles · bigger circle = more articles
Show as table
Co-authorOrganisationJoint articles
Kartuti DeboraUniversitas Airlangga3
Kuntaman KuntamanUniversitas Airlangga3
Endang RetnowatiUniversitas Airlangga2
Oryza Dwi NandaUniversitas Airlangga1
Bambang WiryantoUniversitas Airlangga1
Intan Putri Risky AmaliaUniversitas Airlangga1
Rachmat HargonoUniversitas Airlangga1
Nursalam NursalamUniversitas Airlangga1
Dhian Satya RachmawatiSTIKES Hang Tuah Surabaya1
Siti Rahayu NadhirohUniversitas Airlangga1
Alfadhila Khairil SinatryaUniversitas Airlangga1
Hazreen Abdul MajidUniversity of Malaya1
Lailatul FitriaUniversitas Airlangga1
Armedy Ronny HasugianNational Research and Innovation Agency1
Nono Tri NugrohoRumah Sakit Dokter Soetomo1
Riyanarto SarnoInstitut Teknologi Sepuluh Nopember1
Muhammad RivaiInstitut Teknologi Sepuluh Nopember1
Kelly Rossa SungkonoInstitut Teknologi Sepuluh Nopember1
Alfian Nur RosyidUniversitas Airlangga1
Dava AuliaInstitut Teknologi Sepuluh Nopember1
Harumi Iring PrimastutiMuhammadiyah University of Yogyakarta1
Merita AriniMuhammadiyah University of Yogyakarta1
Wan Hasliza Wan MamatInternational Islamic University Malaysia1
Edwin TohagaMuhammadiyah University of Yogyakarta1
Desiani Wahyu UtamiMuhammadiyah University of Yogyakarta1
Warkim SutartoMuhammadiyah University of Yogyakarta1
Fauzan AdimaMuhammadiyah University of Yogyakarta1
Abdul Latif KurniawanMuhammadiyah University of Yogyakarta1
Teuku Ilham NoeryosanMuhammadiyah University of Yogyakarta1
Budi UtomoUniversitas Airlangga1
Achmad BasoriUniversitas Airlangga1
Amaliyah Nurul HidayahAkademi Farmasi Jember1
Isnaeni IsnaeniUniversitas Airlangga1
Ardhiya PuspitaUniversitas Airlangga1
Radita Yuniar ArizandyUniversitas Airlangga1
Ishak Samuel WuwutiUniversitas Airlangga1
Anita Rahmadani AdnanAffiliation unknown1

Affiliations come from OpenAlex; journal OAI-PMH metadata carries none. Authors without an OpenAlex ID are matched by name, which can merge or split people.

Metadata source: OpenAlex API (jurnal SINTA, ADR 0048) https://openalex.org/S4210179714, first harvested 19 Nov 2026, last seen 19 Nov 2026.
Original metadata (oai_dc)
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"><dc:title xml:lang="en">Comparison between Exposure of Ciprofloxacin and Cefotaxime on Developing of Escherichia coli ESBL</dc:title><dc:creator>Muhammad Amin</dc:creator><dc:creator>Eddy Bagus Wasito</dc:creator><dc:creator>Erwin Astha Triyono</dc:creator><dc:subject>ciprofloxacin</dc:subject><dc:subject>cefotaxime</dc:subject><dc:subject>extended-spectrum beta-lactamase</dc:subject><dc:subject>ESBL-producing Escherichia coli</dc:subject><dc:subject>antibiotic exposure</dc:subject><dc:subject>antibiotic resistance development</dc:subject><dc:subject>ceftazidime</dc:subject><dc:subject>aztreonam</dc:subject><dc:subject>amoxicillin-clavulanic acid</dc:subject><dc:subject>beta-lactamase induction</dc:subject><dc:description xml:lang="en">This study aimed to compare ciprofloxacin and cefotaxime exposure to develop ESBL producing Escherichia coli (E. coli). A total of 16 isolates of cefotaxime sensitive E. coli and ciprofloxacin were exposed to ciprofloxacin and cefotaxime for 14 days using the Kirby-Bauer antibiotic disc diffusion method. Colonies that grew on the edge of the inhibiting zone were exposed each day by the same method. Furthermore, we observed the occurrence of resistance to cefotaxime as ESBL screening test. Isolates were resistant, the following day the ESBL was confirmed by the Modified Double Disk Sinergy Test (MDDST) method using Cefotaxime (CTX), Ceftazidime (CAZ), Aztreonam (ATM), and Amoxilin Clavulanate (AMC) antibiotic discs. From 16 isolates of ESBL producing E. coli exposed to ciprofloxacin, it was obtained 4 (25%) to ESBL E. coli. ESBL production occurred after E. coli was exposed to ciprofloxacin on days 5, 6, 7, and 12. While those exposed to cefotaxime none becomes ESBL E. coli. There was no difference between ciprofloxacin and cefotaxime exposure to develop ESBL producing E. coli (p=0.101; Chi-square).</dc:description><dc:publisher>Airlangga University</dc:publisher><dc:date>2020-08-06</dc:date><dc:type>info:eu-repo/semantics/article</dc:type><dc:format>application/pdf</dc:format><dc:identifier>https://doi.org/10.20473/fmi.v56i2.21203</dc:identifier><dc:identifier>10.20473/fmi.v56i2.21203</dc:identifier><dc:source>Folia Medica Indonesiana; Vol 56 No 2 (2020); 86-86</dc:source><dc:source>2355-8393</dc:source><dc:source>2599-056X</dc:source><dc:language>en</dc:language><dc:relation>https://e-journal.unair.ac.id/FMI/article/download/21203/11714</dc:relation><dc:rights>https://creativecommons.org/licenses/by-nc-sa/4.0/</dc:rights></oai_dc:dc>